Marta Iannuccelli

University of Rome Tor Vergata — Italy

Biochemistry, Genetics and Molecular Biology · Life Sciences

18h-index5.0kcitations50works0.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Bioinformatics and Genomic Networks(28), Computational Drug Discovery Methods(19), Genomics and Chromatin Dynamics(6), Acute Myeloid Leukemia Research(6), Biomedical Text Mining and Ontologies(6)

Publications50 total

SIGNOR 4.0: the 2025 update with focus on phosphorylation data
Nucleic Acids Research·2025· 2 citedOpen Access
Unveiling the signaling network of FLT3-ITD AML improves drug sensitivity prediction
eLife·2024Open Access
None: Unveiling the signaling network of FLT3-ITD AML improves drug sensitivity prediction
2024Open Access
Unveiling the signaling network of FLT3-ITD AML improves drug sensitivity prediction
2024Open Access
Reviewer #3 (Public Review): Unveiling the signaling network of FLT3-ITD AML improves drug sensitivity prediction
2024Open Access
None: Unveiling the signaling network of FLT3-ITD AML improves drug sensitivity prediction
2024Open Access
Reviewer #1 (Public Review): Unveiling the signaling network of FLT3-ITD AML improves drug sensitivity prediction
2024Open Access
Reviewer #2 (Public Review): Unveiling the signaling network of FLT3-ITD AML improves drug sensitivity prediction
2024Open Access
Correction: Curation of causal interactions mediated by genes associated with autism accelerates the understanding of gene-phenotype relationships underlying neurodevelopmental disorders
Molecular Psychiatry·2024· 2 citedOpen Access
Curation of causal interactions mediated by genes associated with autism accelerates the understanding of gene-phenotype relationships underlying neurodevelopmental disorders
Molecular Psychiatry·2023· 9 citedOpen Access
Unveiling the signaling network of FLT3-ITD AML improves drug sensitivity prediction
2023Open Access
Unveiling the signaling network of FLT3-ITD AML improves drug sensitivity prediction
eLife·2023· 6 citedOpen Access
Reviewer #3 (Public Review): Unveiling the signaling network of FLT3-ITD AML improves drug sensitivity prediction
2023Open Access
Reviewer #1 (Public Review): Unveiling the signaling network of FLT3-ITD AML improves drug sensitivity prediction
2023Open Access
Reviewer #2 (Public Review): Unveiling the signaling network of FLT3-ITD AML improves drug sensitivity prediction
2023Open Access
Unveiling the signaling network of FLT3-ITD AML improves drug sensitivity prediction
2023· 1 citedOpen Access
Curation of causal interactions mediated by genes associated to autism accelerates the understanding of gene-phenotype relationships underlying neurodevelopmental disorders
2023· 11 citedOpen Access
SIGNOR 3.0, the SIGnaling network open resource 3.0: 2022 update
Nucleic Acids Research·2022· 160 citedOpen Access
A Resource to Infer Molecular Paths Linking Cancer Mutations to Perturbation of Cell Metabolism
Frontiers in Molecular Biosciences·2022· 3 citedOpen Access
The Intricacy of the Viral-Human Protein Interaction Networks: Resources, Data, and Analyses
Frontiers in Microbiology·2022· 5 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Livia Perfetto(41), Luana Licata(33), Gianni Cesareni(27), Francesca Sacco(26), Luisa Castagnoli(21), Giorgia Massacci(15), Sara Latini(14), Giusj Monia Pugliese(14), Simone Graziosi(14), Veronica Venafra(13), Valeria Bica(13), Filippo Frioni(13), Gessica Minnella(13), John Donald Marra(13), Patrizia Chiusolo(13), Gerardo Pepe(13), Manuela Helmer‐Citterich(13), Pablo Porras(11), Prisca Lo Surdo(11), Thomas Fischer(10)